Some children with coeliac disease show behavioural disorders such as depression and other signs which have been correlated with reduced central monoamine metabolism. We have therefore investigated the brain availability of the monoamine precursors tryptophan and tyrosine in 15 untreated children with coeliac disease and 12 treated children with coeliac disease as well as in 12 control children. Significantly decreased plasma concentrations of tryptophan were found in untreated children (mean (SD) 13 (4) ,mol/l, p<0.001) compared with treated children (31 (13) ,mol/l), and in both groups of coeliac children when compared with control children (81 (22) gumoUll). A significantly lower ratio of plasma tryptophan to large neutral amino acids (tyrosine, valine, isoleucine, leucine, and phenylalanine) was also observed, which could indicate impaired brain availability of tryptophan in coeliac children and was more pronounced in untreated children. The impaired availability of tryptophan could produce decreased central serotonin synthesis and in turn behaviour disorders in children with coeliac disease.
Untreated coeliac disease is known to be associated with an abnormal intestinal mucosa,'2 which produces biochemical and immunological abnormalities.3 However, coeliac disease also produces neurological and psychiatric complications in children. Behavioural disorders such as schizophrenia, depression, and obsessional neurosis have been described in adults65 and rarely in children9`0 with coeliac disease.
Affective disorders have long been related to monoamine production in the central nervous system. 8 Thus there is some evidence that depressed patients may have decreased plasma concentrations of tryptophan." 12 The biogenic amines are synthesised in neurones from precursor amino acids circulating in blood '3 and cross the blood-brain barrier by specific transport mechanisms. 14 Catecholamines are synthesised from tyrosine and serotonin from tryptophan (essential amino acid). However, concentrations of tyrosine and tryptophan in the brain depend not only on the plasma concentrations but also on the plasma concentration of large neutral amino acids competing for transport in this system. '5 Thus amino acid availability in plasma regulates the monoamine turnover in the central nervous system. '5 There is little information available on precursor amino acids of monoamines in adult coeliac disease '6 On the other hand, both treated and untreated children had significantly decreased plasma concentrations of citrulline, tyrosine, valine, isoleucine, and leucine compared with control children. Moreover, asparagine, glycine, taurine, histidine, arginine, proline, methionine, ornithine, and lysine concentrations were significantly decreased in untreated children compared with control children.
The ratio of plasma tryptophan to the sum of large neutral amino acids (tyrosine, valine, isoleucine, leucine, and phenylalanine), called the 'plasma tryptophan ratio' (Fig 1), (0 024) mean (SD)) and treated children (0-021 (0 003), p<0-001 compared with control children) and untreated children (0-010 (0 002), p<0 00I compared with control children) as well as between treated and untreated children (p<0001). Moreover, this ratio was lower in untreated children with behavioural disturbances (0-008 (0 003), p<0 05) than in untreated children without these symptoms (0-012 (0-002)). However, the ratio of plasma tyrosine to the sum of valine, isoleucine, leucine, phenylalanine, and tryptophan, known as the 'plasma tyrosine ratio' (Fig 2) , showed no difference between control children (0-121 (0 026)) and treated (0 122 (002 1)) and untreated (0 110 (0 029)) children.
Discussion
Our results show that children with treated and untreated coeliac disease have decreased tyrosine concentrations in plasma compared with control children. Also, plasma concentrations of other larger neutral amino acids such as valine, isoleucine, and leucine, but not phenylalanine, were significantly decreased in both treated and untreated children. These decreased levels of larger neutral amino acids could explain the normal plasma tyrosine ratio found in both coeliac groups compared with the control group. This ratio is thought to indicate the availability of tyrosine to the brain according to Fernstrom and Faller. 14 Plasma tryptophan concentrations were significantly lower in untreated and treated children than in control children. Regardless of the existence of significantly decreased plasma concentrations of larger neutral amino acids other than phenylalanine, the tryptophan ratio was diminished in both the treated and untreated groups. In this case the decrease in the plasma tryptophan ratio is due to the considerable fall in plasma tryptophan concentrations. Thus the lower plasma tryptophan ratio might indicate that all children with coeliac disease have impaired availability of tryptophan in the brain, such impairment being greatest in untreated children with symptoms of behavioural disturbances, in which the tryptophan ratio was most significantly decreased (see Results). The findings of this study regarding plasma tryptophan concentrations and the plasma tryptophan ratio to some extent do not agree with the observations reported by Hallert et al '6 in untreated adult patients with coeliac disease. Only four of 11 untreated adults showed a significant decrease in the plasma tryptophan ratio compared with adult controls,'6 and three of them had a psychiatric illness. In our study all untreated children had decreased plasma tryptophan concentrations, but only nine of 15 had signs of behavioural disturbances. In addition, the plasma tyrosine ratio was found to be normal in adult patients,'6 as in the present study.
The low tryptophan concentrations seen in both treated and untreated children could indicate the existence of metabolic reactions reducing transport of dietary tryptophan to the brain rather than impaired absorption,"6 since according to Hallert et al'6 untreated adults and control subjects showed a similar rise in plasma tryptophan after oral casein administration. Our findings also suggest that tryptophan was decreased in plasma metabolically rather than by reduced absorption because other essential amino acids such as valine, isoleucine, and leucine were also reduced in both treated and untreated groups independently of jejunal mucosa integrity. Moreover, the existence of normal plasma values of phenylalanine and threonine, which are essential amino acids and must be absorbed by the intestinal tract, supports the hypothesis ofan altered metabolism to explain the greatly decreased tryptophan concentrations in the plasma of children with coeliac disease. We think, however, that these changes in tryptophan might not be specific to coeliac disease and that they might be altered in a similar way in other enteropathic diseases.
The impaired availability of tryptophan to the brain in the untreated children may explain signs of reduced serotonin synthesis in the central nervous system, such as depression'9 or other affective disorders, which were found9 or described'0 in children with coeliac disease. These behavioural disturbances are frequently seen in our children at the onset of the disease. These patients can be irritable, querulous, depressive, apathetic, or negate, and they also may present stereotyped movements. An improvement in mood and mental activity has been seen in our patients after a period on a gluten free diet, and it has also been recognised by experienced physicians.
In our study, nine of 15 untreated children with coeliac disease presented signs of behavioural disturbances (irritability and apathy). These untreated children had significantly lower plasma tryptophan ratios than children without behavioural symptoms. Thus, there seems to be a relation between behavioural disturbances and greatly decreased tryptophan ratios. However, there was no relation between the severity of coeliac disease, determined by clinical, histological, or biochemical data, and the plasma tryptophan ratio.
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